BETA DRUGS
Back to Cashflow Statement
|
BETA DRUGS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹36 Cr | ₹31 Cr | ₹23 Cr | ₹30 Cr | ₹19 Cr |
What is the latest Cash Flow from Operating Activities ratio of BETA DRUGS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹36 Cr |
| Mar2024 | ₹31 Cr |
| Mar2023 | ₹23 Cr |
| Mar2022 | ₹30 Cr |
| Mar2021 | ₹19 Cr |
How is Cash Flow from Operating Activities of BETA DRUGS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹36 Cr | 16.86 | |
| Mar2024 | ₹31 Cr | 32.28 | |
| Mar2023 | ₹23 Cr | -21.08 | |
| Mar2022 | ₹30 Cr | 59.29 | |
| Mar2021 | ₹19 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,443.1 Cr | -4.6% | -0.1% | 12.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹460,696.0 Cr | 0.5% | -4% | 15.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹246,063.0 Cr | 9.1% | 18.2% | 47.1% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,515.0 Cr | 3.6% | 3.4% | 36.4% | Stock Analytics | |
| CIPLA | ₹114,554.0 Cr | -1.2% | -3.3% | -10.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,308.6 Cr | -1.4% | 2.9% | -8% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | -4.6% |
-0.1% |
12.8% |
| SENSEX | -0.4% |
-0.5% |
-5.8% |
You may also like the below Video Courses